[1] |
ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing.
Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940.
|
[2] |
ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng.
Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943.
|
[3] |
WANG Hao, MA Jinfu, MA Rui, LI Xiaogang, ZHAO Qiang, ZHANG Xian.
One Case of Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium for Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 686-688.
|
[4] |
LIU Nannan, XI Yalin, CHEN Zhe.
One Case of Adrenocortical Insufficiency Caused by Cadonilimab
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 109-112.
|
[5] |
YU Wenlu, ZHANG Hong.
Research Progress in Applications of Strychnine Semen in Orthopedics and Traumatology
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 116-120.
|
[6] |
ZHANG Caixia, ZHOU Yi, TAN Lu, CHEN Wenming, LIU Yang, YOU Yu.
Pharmaceutical care of pulmonary aspergillus infection secondary to sepsis
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1064-1067.
|
[7] |
YAN Yan, LIU Naiyi, QIAO Ling, ZHANG Yi, YANG Chen.
One case of fulminant type 1 diabetes mellitus induced by allopurinol tablets hypersensitivity syndrome
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1068-1070.
|
[8] |
LIU Ting, CAO Zhongqiang, HE Wenjia, YUAN Xiuli, CHEN Zebin, LI Xuejuan.
One case of acute severe pancreatitis caused by pegaspargase and its etiology
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1075-1077.
|
[9] |
ZHANG Qian, YUN Yuan, HE Lian.
Pharmaceutical care of hyperprolactinemia in a patient induced by risperidone
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 936-938.
|
[10] |
LIN Yanxin, LIU Yanhui, DONG Jing, YAO Jiachen, LI Wenyan.
Pharmaceutical care of acute liver injury in a patient with colon cancer induced by irinotecan
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 693-696.
|
[11] |
YU Xin, GONG Leilei, YAO Weijie, YUAN Sisi, FENG Xin.
Chinese patent medicines for recurrent spontaneous abortion: a scoping review of clinical evidence
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 361-365.
|
[12] |
LI haiyan, YANG Zhongxu, LIU Yuekun, WANG Lihong.
Pharmaceutical care of serious adverse reactions due to methotrexate treatment of ectopic pregnancy
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 454-456.
|
[13] |
LIU Qi, ZHANG Yufeng, LUO Hao, LI Xin.
Analysis of the rationality and safety of clinical application of anrotinib in a hospital
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 329-334.
|
[14] |
JI Qiuxia, JIN Jian, ZHANG Bin.
Pharmaceutical care for immune-related adverse events induced by toripalimab
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 346-348.
|
[15] |
FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong.
Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184.
|